BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 38582632)

  • 1. Spectral Analysis Based on Hemodynamic Habitat Imaging Predicts Isocitrate Dehydrogenase Status and Prognosis in High-Grade Glioma.
    Qiao J; Wu H; Liu J; Kang H; Wang S; Fang J; Zhang J; Zhang W
    World Neurosurg; 2023 Jul; 175():e520-e530. PubMed ID: 37028478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular habitat analysis based on dynamic susceptibility contrast perfusion MRI predicts IDH mutation status and prognosis in high-grade gliomas.
    Wu H; Tong H; Du X; Guo H; Ma Q; Zhang Y; Zhou X; Liu H; Wang S; Fang J; Zhang W
    Eur Radiol; 2020 Jun; 30(6):3254-3265. PubMed ID: 32078014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatiotemporal Heterogeneity in Multiparametric Physiologic MRI Is Associated with Patient Outcomes in IDH-Wildtype Glioblastoma.
    Park JE; Kim HS; Kim N; Park SY; Kim YH; Kim JH
    Clin Cancer Res; 2021 Jan; 27(1):237-245. PubMed ID: 33028594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioma grading using multiparametric MRI: head-to-head comparison among dynamic susceptibility contrast, dynamic contrast-enhancement, diffusion-weighted images, and MR spectroscopy.
    Seo M; Choi Y; Soo Lee Y; Ahn KJ; Kim BS; Park JS; Jeon SS
    Eur J Radiol; 2023 Aug; 165():110888. PubMed ID: 37257338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association between Whole-Brain MR Spectroscopy and IDH Mutation Status in Gliomas.
    Goryawala M; Saraf-Lavi E; Nagornaya N; Heros D; Komotar R; Maudsley AA
    J Neuroimaging; 2020 Jan; 30(1):58-64. PubMed ID: 31868291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
    Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic habitat imaging with hemodynamic heterogeneity predicts individual progression-free survival in high-grade glioma.
    Qiao J; Kang H; Ran Q; Tong H; Ma Q; Wang S; Zhang W; Wu H
    Clin Radiol; 2024 Jun; 79(6):e842-e853. PubMed ID: 38582632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal differentiation of high- and low-grade glioma and metastasis: a meta-analysis of perfusion, diffusion, and spectroscopy metrics.
    Usinskiene J; Ulyte A; Bjørnerud A; Venius J; Katsaros VK; Rynkeviciene R; Letautiene S; Norkus D; Suziedelis K; Rocka S; Usinskas A; Aleknavicius E
    Neuroradiology; 2016 Apr; 58(4):339-50. PubMed ID: 26767528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis.
    Wang Q; Zhang H; Zhang J; Wu C; Zhu W; Li F; Chen X; Xu B
    Eur Radiol; 2016 Aug; 26(8):2670-84. PubMed ID: 26471274
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.